WallStreetZenWallStreetZen

NASDAQ: DSGN
Design Therapeutics Inc Earnings & Revenue

DSGN past revenue growth

How has DSGN's revenue growth performed historically?
Company
N/A
Industry
91.53%
Market
19.5%
DSGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DSGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

DSGN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$58.7M
Current Profit Margin
0%

DSGN Return on Equity

Current Company
-20.8%
Current Industry
16.8%
Current Market
28.2%
DSGN's Return on Equity (-20.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DSGN announces earnings.

DSGN Return on Assets

Current Company
-19.9%
Current Industry
3.2%
DSGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DSGN Return on Capital Employed

Current Company
-21.59%
Current Industry
-42.4%
DSGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DSGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DSGN$0.00-$58.10M-$58.67M-100.00%N/A
CBUS$2.32M-$253.18M-$285.67M+43.44%N/A
ALDX$0.00-$27.67M-$30.01MN/AN/A
NBTX$38.93M-$25.02M-$42.69M+58.68%N/A
TSVT$71.20M-$213.09M-$223.22M+18.10%N/A

DSGN earnings dates

Next earnings date
Aug 12, 2024

Design Therapeutics Earnings & Revenue FAQ

What were DSGN's earnings last quarter?

On Invalid Date, Design Therapeutics (NASDAQ: DSGN) reported Q1 2024 earnings per share (EPS) of -$0.20, up 42.86% year over year. Total Design Therapeutics earnings for the quarter were -$11.11 million. In the same quarter last year, Design Therapeutics's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Design Therapeutics stock.

What was DSGN's earnings growth in the past year?

As of Q3 2024, Design Therapeutics's earnings has grown year over year. Design Therapeutics's earnings in the past year totalled -$58.67 million.

What is DSGN's earnings date?

Design Therapeutics's earnings date is Invalid Date. Add DSGN to your watchlist to be reminded of DSGN's next earnings announcement.

What was DSGN's revenue last quarter?

On Invalid Date, Design Therapeutics (NASDAQ: DSGN) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Design Therapeutics's revenue was $0.00.

What was DSGN's revenue growth in the past year?

As of Q3 2024, Design Therapeutics's revenue has grown null year over year. Design Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.